GEOVAX LABS INC Share Price Today: Live Updates & Key Insights
GEOVAX LABS INC share price today is $1.46, up 2.8%. The stock opened at $1.4601 against the previous close of $1.43, with an intraday high of $1.48 and low of $1.33.
GEOVAX LABS INC Share Price Chart
GEOVAX LABS INC
GEOVAX LABS INC Share Price Performance
GEOVAX LABS INC Institutional Holdings
GEOVAX LABS INC Market Status
GEOVAX LABS INC Fundamentals
Market Cap 3.27 M
PB Ratio 0.6616
PE Ratio 0.0
Enterprise Value 1.83 M
Total Assets 8.16 M
Volume 147801
GEOVAX LABS INC Company Financials
About GEOVAX LABS INC & investment objective
Company Information GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. It also developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, the company offers GEO-MVA-MUC1, a vaccine candidate, which is in preclinical trial for the treatment of solid tumor cancers; GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-EMO1-Z, which is in preclinical trial for the treatment of Ebola Zaire; GEO-EMO1-S, which is in preclinical trial for the treatment of Ebola Sudan; GEO-MM01 treatment for marburg; and GEO-MVA for the treatment of Mpox and small pox. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.
Organisation Biotechnology
Employees 17
Industry Biotechnology
CEO Mr. David Alan Dodd
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
GEOVAX LABS INC FAQs
What is the share price of GEOVAX LABS INC today?
The current share price of GEOVAX LABS INC is $1.46.
Can I buy GEOVAX LABS INC shares in India?
Yes, Indian investors can buy GEOVAX LABS INC shares by opening an international trading and demat account with Motilal Oswal.
How to buy GEOVAX LABS INC shares in India?
You can easily invest in GEOVAX LABS INC shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy GEOVAX LABS INC shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of GEOVAX LABS INC.
Can I buy fractional shares of GEOVAX LABS INC?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of GEOVAX LABS INC?
GEOVAX LABS INC has a market cap of $3.27 M.
In which sector does GEOVAX LABS INC belong?
GEOVAX LABS INC operates in the Biotechnology sector.
What documents are required to invest in GEOVAX LABS INC stocks?
To invest, you typically need:
What is the PE and PB ratio of GEOVAX LABS INC?
The PE ratio of GEOVAX LABS INC is N/A and the PB ratio is 0.66.